Theragnostic Imaging
Theragnostic Imaging
News
People
Events
Publications
RNTreg
Contact
Ulf Erik Madsbu
Latest
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma